CEMI

Chembio Diagnostics, Inc. News Headlines

$3.9684
*  
0.1116
2.74%
Get CEMI Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading CEMI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CEMI Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
AEZS To Watch Out, RCPT Surges In Afterhours, CEMI Focuses On Ebola, PTIE Hurt
10/28/2014 12:39:00 AM - RTT News


Zacks Rank #1 Additions for Tuesday - Tale of the Tape
5/13/2014 8:30:00 AM - Zacks.com


Alere Beats, Earnings Up 40.5% - Analyst Blog
8/7/2013 11:15:01 AM - Zacks.com


SA Pro Insider's Report, Monday August 5
8/6/2013 7:45:00 AM - Seeking Alpha


SA Pro Insider's Report, Friday June 28
6/29/2013 7:45:00 AM - Seeking Alpha


Chembio: A Potentially Undervalued Diagnostics Biotech
5/2/2013 1:48:00 PM - Seeking Alpha


Chembio Caps 2012 With Another Revenue Record
3/12/2013 1:10:00 PM - Seeking Alpha


Medtech News Over The Christmas Period
1/2/2013 11:57:00 AM - Seeking Alpha


Chembio Diagnostics: Growing Sales And Profits With Near-Term FDA Catalyst
12/20/2012 10:12:00 AM - Seeking Alpha


Profiting From The Trend Towards Point Of Care Diagnostics
11/20/2012 4:19:00 PM - Seeking Alpha


Q3: DPP Sales Up 49% Despite Revenue Miss - Analyst Blog
11/13/2012 5:17:01 PM - Zacks.com


USPSTF Decision Could Benefit CEMI - Analyst Blog
8/21/2012 1:56:01 PM - Zacks.com


USPSTF Decision Could Benefit CEMI - Analyst Blog
8/21/2012 10:20:01 AM - Zacks.com


OSUR Approval Green-Light's CEMI's OTC Program? - Analyst Blog
7/5/2012 6:06:01 PM - Zacks.com


CEMI: Study May Offer Support for DPP HCV Test - Analyst Blog
6/19/2012 11:53:24 AM - Zacks.com


CEMI: Deja vu: Another Record Quarter, Another Top-line Beat - Analyst Blog
5/9/2012 10:17:15 AM - Zacks.com


CEMI: D??j?? vu: Another Record Quarter, Another Top-line Beat - Analyst Blog
5/9/2012 10:04:01 AM - Zacks.com


Med-tech Companies to Watch in 2012 - Analyst Blog
1/9/2012 6:07:01 AM - Zacks.com